Genome Sequencing Isn’t Predictive of Most Diseases, Study Says

Sequencing the genomes of patients to reveal what ailments might mar their futures isn’t the best predictor for the most common diseases, according to a study involving thousands of identical twins.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.